These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10916181)

  • 1. Full-field ERG in patients with Batten/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene.
    Eksandh LB; Ponjavic VB; Munroe PB; Eiberg HE; Uvebrant PE; Ehinger BE; Mole SE; Andréasson S
    Ophthalmic Genet; 2000 Jun; 21(2):69-77. PubMed ID: 10916181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
    Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and magnetic resonance imaging findings in Batten disease: analysis of the major mutation (1.02-kb deletion).
    Järvelä I; Autti T; Lamminranta S; Aberg L; Raininko R; Santavuori P
    Ann Neurol; 1997 Nov; 42(5):799-802. PubMed ID: 9392580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations in the arrestin gene and associated clinical features in Japanese patients with Oguchi's disease.
    Nakamura M; Yamamoto S; Okada M; Ito S; Tano Y; Miyake Y
    Ophthalmology; 2004 Jul; 111(7):1410-4. PubMed ID: 15234147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Batten disease--deteriorating course of ocular findings.
    Horiguchi M; Miyake Y
    Jpn J Ophthalmol; 1992; 36(1):91-6. PubMed ID: 1635301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubby-like protein 1 homozygous splice-site mutation causes early-onset severe retinal degeneration.
    Lewis CA; Batlle IR; Batlle KG; Banerjee P; Cideciyan AV; Huang J; Alemán TS; Huang Y; Ott J; Gilliam TC; Knowles JA; Jacobson SG
    Invest Ophthalmol Vis Sci; 1999 Aug; 40(9):2106-14. PubMed ID: 10440267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone dystrophy with supernormal rod response is strictly associated with mutations in KCNV2.
    Wissinger B; Dangel S; Jägle H; Hansen L; Baumann B; Rudolph G; Wolf C; Bonin M; Koeppen K; Ladewig T; Kohl S; Zrenner E; Rosenberg T
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):751-7. PubMed ID: 18235024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel NR2E3 mutations (R104Q, R334G) associated with a mild form of enhanced S-cone syndrome demonstrate compound heterozygosity.
    Hayashi T; Gekka T; Goto-Omoto S; Takeuchi T; Kubo A; Kitahara K
    Ophthalmology; 2005 Dec; 112(12):2115. PubMed ID: 16225923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high association with cone dystrophy in Fundus albipunctatus caused by mutations of the RDH5 gene.
    Nakamura M; Hotta Y; Tanikawa A; Terasaki H; Miyake Y
    Invest Ophthalmol Vis Sci; 2000 Nov; 41(12):3925-32. PubMed ID: 11053295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autosomal recessive bestrophinopathy: differential diagnosis and treatment options.
    Boon CJ; van den Born LI; Visser L; Keunen JE; Bergen AA; Booij JC; Riemslag FC; Florijn RJ; van Schooneveld MJ
    Ophthalmology; 2013 Apr; 120(4):809-20. PubMed ID: 23290749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal degeneration in motor neuron degeneration: a mouse model of ceroid lipofuscinosis.
    Chang B; Bronson RT; Hawes NL; Roderick TH; Peng C; Hageman GS; Heckenlively JR
    Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1071-6. PubMed ID: 8125718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic variation in enhanced S-cone syndrome.
    Audo I; Michaelides M; Robson AG; Hawlina M; Vaclavik V; Sandbach JM; Neveu MM; Hogg CR; Hunt DM; Moore AT; Bird AC; Webster AR; Holder GE
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):2082-93. PubMed ID: 18436841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variant phenotype of Best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2.
    Schatz P; Klar J; Andréasson S; Ponjavic V; Dahl N
    Ophthalmic Genet; 2006 Jun; 27(2):51-6. PubMed ID: 16754206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical findings in a carrier of a new mutation in the choroideremia gene.
    Potter MJ; Wong E; Szabo SM; McTaggart KE
    Ophthalmology; 2004 Oct; 111(10):1905-9. PubMed ID: 15465555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Juvenile neuronal ceroid lipofuscinosis].
    Ostergaard JR; Hertz JM
    Ugeskr Laeger; 1998 Jun; 160(26):3895-900. PubMed ID: 9656828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A variant form of Oguchi disease mapped to 13q34 associated with partial deletion of GRK1 gene.
    Zhang Q; Zulfiqar F; Riazuddin SA; Xiao X; Yasmeen A; Rogan PK; Caruso R; Sieving PA; Riazuddin S; Hejtmancik JF
    Mol Vis; 2005 Nov; 11():977-85. PubMed ID: 16319817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.